venBio Global Strategic Fund II L.P.

person

Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.

Political giving

—

Political receipts

—

Lobbying income

—

Lobbying expense

—

Federal awards

—

Relationships

Connected records

Relationship	Connected entity	Amount / weight	Period
insider of	VYNE Therapeutics Inc.	4,505,000	Jan 25, 2018 – Jan 29, 2018
insider of	Apellis Pharmaceuticals, Inc.	1,785,210	Nov 13, 2017 – Nov 13, 2017

Source coverage

sec insider: 0001634632

venBio Global Strategic Fund II L.P. — Influence Profile | Poliscope